JAZZ vs RELL · P/E 1988, rev $4.07B vs rev $51.9M
Jazz Pharmaceuticals PLC (JAZZ) versus Richardson Electronics Ltd (RELL) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Richardson Electronics Ltd (RELL) is a electronic components company listed on US.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported RELL revenue for 2025-05-31 was $51.9M. Net income was -$1.1M. Revenue was down 3.6% from 2025-03-01 to 2025-05-31. RELL currently screens at market cap $141.1M.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. RELL currently screens at market cap $141.1M.
Not investment advice. Open the JAZZ and RELL stock pages for the full models.
Not investment advice.